BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 33253230)

  • 1. Mining GWAS and eQTL data for CF lung disease modifiers by gene expression imputation.
    Dang H; Polineni D; Pace RG; Stonebraker JR; Corvol H; Cutting GR; Drumm ML; Strug LJ; O'Neal WK; Knowles MR
    PLoS One; 2020; 15(11):e0239189. PubMed ID: 33253230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Airway Mucosal Host Defense Is Key to Genomic Regulation of Cystic Fibrosis Lung Disease Severity.
    Polineni D; Dang H; Gallins PJ; Jones LC; Pace RG; Stonebraker JR; Commander LA; Krenicky JE; Zhou YH; Corvol H; Cutting GR; Drumm ML; Strug LJ; Boyle MP; Durie PR; Chmiel JF; Zou F; Wright FA; O'Neal WK; Knowles MR
    Am J Respir Crit Care Med; 2018 Jan; 197(1):79-93. PubMed ID: 28853905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Modifiers of Cystic Fibrosis Lung Disease Severity: Whole-Genome Analysis of 7,840 Patients.
    Zhou YH; Gallins PJ; Pace RG; Dang H; Aksit MA; Blue EE; Buckingham KJ; Collaco JM; Faino AV; Gordon WW; Hetrick KN; Ling H; Liu W; Onchiri FM; Pagel K; Pugh EW; Raraigh KS; Rosenfeld M; Sun Q; Wen J; Li Y; Corvol H; Strug LJ; Bamshad MJ; Blackman SM; Cutting GR; Gibson RL; O'Neal WK; Wright FA; Knowles MR
    Am J Respir Crit Care Med; 2023 May; 207(10):1324-1333. PubMed ID: 36921087
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetic association and transcriptome integration identify contributing genes and tissues at cystic fibrosis modifier loci.
    Gong J; Wang F; Xiao B; Panjwani N; Lin F; Keenan K; Avolio J; Esmaeili M; Zhang L; He G; Soave D; Mastromatteo S; Baskurt Z; Kim S; O'Neal WK; Polineni D; Blackman SM; Corvol H; Cutting GR; Drumm M; Knowles MR; Rommens JM; Sun L; Strug LJ
    PLoS Genet; 2019 Feb; 15(2):e1008007. PubMed ID: 30807572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung disease modifier genes in cystic fibrosis.
    Guillot L; Beucher J; Tabary O; Le Rouzic P; Clement A; Corvol H
    Int J Biochem Cell Biol; 2014 Jul; 52():83-93. PubMed ID: 24569122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FAM13A is a modifier gene of cystic fibrosis lung phenotype regulating rhoa activity, actin cytoskeleton dynamics and epithelial-mesenchymal transition.
    Corvol H; Rousselet N; Thompson KE; Berdah L; Cottin G; Foussigniere T; Longchampt E; Fiette L; Sage E; Prunier C; Drumm M; Hodges CA; Boëlle PY; Guillot L
    J Cyst Fibros; 2018 Mar; 17(2):190-203. PubMed ID: 29239766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation at modifier genes of lung disease severity is altered in cystic fibrosis.
    Magalhães M; Rivals I; Claustres M; Varilh J; Thomasset M; Bergougnoux A; Mely L; Leroy S; Corvol H; Guillot L; Murris M; Beyne E; Caimmi D; Vachier I; Chiron R; De Sario A
    Clin Epigenetics; 2017; 9():19. PubMed ID: 28289476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A flexible summary statistics-based colocalization method with application to the mucin cystic fibrosis lung disease modifier locus.
    Wang F; Panjwani N; Wang C; Sun L; Strug LJ
    Am J Hum Genet; 2022 Feb; 109(2):253-269. PubMed ID: 35065708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystic Fibrosis Lung Disease Modifiers and Their Relevance in the New Era of Precision Medicine.
    Sepahzad A; Morris-Rosendahl DJ; Davies JC
    Genes (Basel); 2021 Apr; 12(4):. PubMed ID: 33924524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystic Fibrosis Disease Modifiers: Complex Genetics Defines the Phenotypic Diversity in a Monogenic Disease.
    O'Neal WK; Knowles MR
    Annu Rev Genomics Hum Genet; 2018 Aug; 19():201-222. PubMed ID: 29709203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leveraging lung tissue transcriptome to uncover candidate causal genes in COPD genetic associations.
    Lamontagne M; Bérubé JC; Obeidat M; Cho MH; Hobbs BD; Sakornsakolpat P; de Jong K; Boezen HM; ; Nickle D; Hao K; Timens W; van den Berge M; Joubert P; Laviolette M; Sin DD; Paré PD; Bossé Y
    Hum Mol Genet; 2018 May; 27(10):1819-1829. PubMed ID: 29547942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unraveling the complex genetic model for cystic fibrosis: pleiotropic effects of modifier genes on early cystic fibrosis-related morbidities.
    Li W; Soave D; Miller MR; Keenan K; Lin F; Gong J; Chiang T; Stephenson AL; Durie P; Rommens J; Sun L; Strug LJ
    Hum Genet; 2014 Feb; 133(2):151-61. PubMed ID: 24057835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collaborative Cross Mice Yield Genetic Modifiers for Pseudomonas aeruginosa Infection in Human Lung Disease.
    Lorè NI; Sipione B; He G; Strug LJ; Atamni HJ; Dorman A; Mott R; Iraqi FA; Bragonzi A
    mBio; 2020 Mar; 11(2):. PubMed ID: 32127447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modifier genes in cystic fibrosis lung disease.
    Merlo CA; Boyle MP
    J Lab Clin Med; 2003 Apr; 141(4):237-41. PubMed ID: 12677168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide association meta-analysis identifies five modifier loci of lung disease severity in cystic fibrosis.
    Corvol H; Blackman SM; Boëlle PY; Gallins PJ; Pace RG; Stonebraker JR; Accurso FJ; Clement A; Collaco JM; Dang H; Dang AT; Franca A; Gong J; Guillot L; Keenan K; Li W; Lin F; Patrone MV; Raraigh KS; Sun L; Zhou YH; O'Neal WK; Sontag MK; Levy H; Durie PR; Rommens JM; Drumm ML; Wright FA; Strug LJ; Cutting GR; Knowles MR
    Nat Commun; 2015 Sep; 6():8382. PubMed ID: 26417704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mega-analysis of expression quantitative trait loci in retinal tissue.
    Strunz T; Kiel C; Grassmann F; Ratnapriya R; Kwicklis M; Karlstetter M; Fauser S; Arend N; Swaroop A; Langmann T; Wolf A; Weber BHF
    PLoS Genet; 2020 Sep; 16(9):e1008934. PubMed ID: 32870927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ensemble genomic analysis in human lung tissue identifies novel genes for chronic obstructive pulmonary disease.
    Morrow JD; Cho MH; Platig J; Zhou X; DeMeo DL; Qiu W; Celli B; Marchetti N; Criner GJ; Bueno R; Washko GR; Glass K; Quackenbush J; Silverman EK; Hersh CP
    Hum Genomics; 2018 Jan; 12(1):1. PubMed ID: 29335020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms associated with expression of BPIFA1/BPIFB1 and lung disease severity in cystic fibrosis.
    Saferali A; Obeidat M; Bérubé JC; Lamontagne M; Bossé Y; Laviolette M; Hao K; Nickle DC; Timens W; Sin DD; Postma DS; Strug LJ; Gallins PJ; Paré PD; Bingle CD; Sandford AJ
    Am J Respir Cell Mol Biol; 2015 Nov; 53(5):607-14. PubMed ID: 25574903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Modifiers of Cystic Fibrosis-Related Diabetes Have Extensive Overlap With Type 2 Diabetes and Related Traits.
    Aksit MA; Pace RG; Vecchio-Pagán B; Ling H; Rommens JM; Boelle PY; Guillot L; Raraigh KS; Pugh E; Zhang P; Strug LJ; Drumm ML; Knowles MR; Cutting GR; Corvol H; Blackman SM
    J Clin Endocrinol Metab; 2020 May; 105(5):1401-15. PubMed ID: 31697830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological characterization of expression quantitative trait loci (eQTLs) showing tissue-specific opposite directional effects.
    Mizuno A; Okada Y
    Eur J Hum Genet; 2019 Nov; 27(11):1745-1756. PubMed ID: 31296926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.